Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experience
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F15%3A33150782" target="_blank" >RIV/61989592:15110/15:33150782 - isvavai.cz</a>
Alternative codes found
RIV/00098892:_____/15:#0000898
Result on the web
<a href="http://dx.doi.org/10.4149/neo_2015_019" target="_blank" >http://dx.doi.org/10.4149/neo_2015_019</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.4149/neo_2015_019" target="_blank" >10.4149/neo_2015_019</a>
Alternative languages
Result language
angličtina
Original language name
Acute promyelocytic leukemia successfully treated also in elderly patients with significant comorbidities: a 20-year single-center experience
Original language description
Acute promyelocytic leukemia is a unique entity among acute leukemias. Introduction of all-trans retinoic acid and, subsequently, arsenic trioxide in its treatment has markedly improved treatment outcomes for this once frequently fatal disease. Improvedoutcomes have also been observed in elderly patients, including those in whom standard intensive therapy is contraindicated because of comorbidities. In our center, a total of 60 APL patients were treated in 1993-2013, of whom 9 were aged 60 or more years. Although most of them had significant comorbidities at the time of diagnosis, eight achieved complete remission. At the time of the analysis, six patients were alive and in long-term remission; two patients died of causes other than APL. The median follow-up was 59 months. Included is case report of a patient with a high comorbidity score whose treatment was markedly reduced and individualized. Our experience shows that, in APL patients a curative approach is generally tolerated and s
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)<br>S - Specificky vyzkum na vysokych skolach
Others
Publication year
2015
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Neoplasma
ISSN
0028-2685
e-ISSN
—
Volume of the periodical
62
Issue of the periodical within the volume
1
Country of publishing house
SK - SLOVAKIA
Number of pages
6
Pages from-to
146-151
UT code for WoS article
—
EID of the result in the Scopus database
—